These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37249550)

  • 1. Cardio-Oncology for the Primary Care Provider.
    Jhawar N; Mcpherson A; Chirila R; Ray J
    Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cardio-Oncology in the Interprofessional Care of Adult Patients Receiving Cancer Therapy.
    Pituskin E; Paterson I; Cox-Kennett N; Rothe D; Perri M; Becher H
    Semin Oncol Nurs; 2017 Nov; 33(4):384-392. PubMed ID: 28941563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
    Lyon AR; Dent S; Stanway S; Earl H; Brezden-Masley C; Cohen-Solal A; Tocchetti CG; Moslehi JJ; Groarke JD; Bergler-Klein J; Khoo V; Tan LL; Anker MS; von Haehling S; Maack C; Pudil R; Barac A; Thavendiranathan P; Ky B; Neilan TG; Belenkov Y; Rosen SD; Iakobishvili Z; Sverdlov AL; Hajjar LA; Macedo AVS; Manisty C; Ciardiello F; Farmakis D; de Boer RA; Skouri H; Suter TM; Cardinale D; Witteles RM; Fradley MG; Herrmann J; Cornell RF; Wechelaker A; Mauro MJ; Milojkovic D; de Lavallade H; Ruschitzka F; Coats AJS; Seferovic PM; Chioncel O; Thum T; Bauersachs J; Andres MS; Wright DJ; López-Fernández T; Plummer C; Lenihan D
    Eur J Heart Fail; 2020 Nov; 22(11):1945-1960. PubMed ID: 32463967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Year in Cardio-oncology 2022.
    Ahmed T; Marmagkiolis K; Ploch M; Irizarry-Caro JA; Amatullah A; Desai S; Aziz MK; Yarrabothula A; Fossas-Espinosa J; Koutroumpakis E; Hassan S; Karimzad K; Kim P; Cilingiroglu M; Iliescu C
    Curr Probl Cardiol; 2023 Jan; 48(1):101435. PubMed ID: 36183977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between cardiology and oncology drugs in precision cardio-oncology.
    Kamaraju S; Mohan M; Zaharova S; Wallace B; McGraw J; Lokken J; Tierney J; Weil E; Fatunde O; Brown SA
    Clin Sci (Lond); 2021 Jun; 135(11):1333-1351. PubMed ID: 34076246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
    Andres MS; Pan J; Lyon AR
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
    Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
    Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-oncology: rationale, aims and future directions.
    Pan J; Garza F; Lyon AR
    Curr Opin Support Palliat Care; 2021 Jun; 15(2):134-140. PubMed ID: 33605633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for Cardio-Oncology Units.
    Nhola LF; Villarraga HR
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):583-589. PubMed ID: 28330611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.
    Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
    Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR
    Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of Primary Care in Cardio-Oncology.
    Cehic DA; Sverdlov AL; Koczwara B; Emery J; Ngo DTM; Thornton-Benko E
    Curr Treat Options Oncol; 2021 Oct; 22(12):107. PubMed ID: 34674055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear cardio-oncology: From its foundation to its future.
    Kahanda MG; Hanson CA; Patterson B; Bourque JM
    J Nucl Cardiol; 2020 Apr; 27(2):511-518. PubMed ID: 30788760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Cardio-Oncology Guideline - A Comprehensive Approach to Managing Cardiovascular Risks in Cancer Patients].
    Romann SW; Frey N; Lehmann L
    Dtsch Med Wochenschr; 2024 Jun; 149(12):719-723. PubMed ID: 38781996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of cardio-oncology.
    Nebigil CG; Désaubry L
    Ann Pharm Fr; 2018 Nov; 76(6):504-506. PubMed ID: 30075937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.